Jazz Pharmaceuticals PLC (JAZZ)
Healthcare
Biotechnology
252.90 $
-2.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Jazz Pharmaceuticals PLC (JAZZ)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 96.8% of the shares are freely tradable; institutional investors hold 108.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
108.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
3.1%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
96.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
6.2%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
63Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.90 | 5,591,700 | +2.6 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 4.75 | 2,983,242 | +0.0 | 03/31/2026 |
| Capital World Investors | 4.26 | 2,673,376 | +0.3 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.22 | 2,648,333 | +0.0 | 03/31/2026 |
| LSV Asset Management | 3.80 | 2,386,840 | -2.8 | 03/31/2026 |
| FMR Inc | 3.62 | 2,275,762 | +184.1 | 03/31/2026 |
| Franklin Resources Inc | 3.12 | 1,958,940 | +7.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.42 | 2,146,775 | +0.1 | 07/28/2026 |
| Capital Group Fundamental Invtrs Comp | 3.34 | 2,100,000 | +0.0 | 06/30/2026 |
| American Funds Fundamental Invs A | 3.34 | 2,100,000 | +0.0 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.